TOI

Oncology Institute Stock Analysis

AI Rating

Neutral
  • Quality0/10
  • Growth↑ 6/10
  • Value↓ 2/10
Oncology Institute sales and earnings growth
TOI Growth
Good
  • Revenue Y/Y↑ 35.37%
  • EPS Y/Y↑ 5.09%
  • FCF Y/Y↓ -34.35%
Oncology Institute gross and profit margin trends
TOI Profitability
Good
  • Gross margin ↑ 15.10%
  • EPS margin↓ -8.50%
  • ROIC 5Y↓ -28.79%
Oncology Institute net debt vs free cash flow
TOI Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 2.9
  • Interest coverage↓ -5.1

Oncology Institute stock volatility is higher than the overall market. We give it a Great risk rating.

↗ More Medical Care Facilities stocks